Chemoinformaics analysis of 3-Hydroxy-1-oxacyclopentacosan-2-one
| Molecular Weight | 382.629 | nRot | 0 |
| Heavy Atom Molecular Weight | 336.261 | nRig | 26 |
| Exact Molecular Weight | 382.345 | nRing | 1 |
| Solubility: LogS | -5.633 | nHRing | 1 |
| Solubility: LogP | 8.249 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 73.1585 |
| nHD | 1 | BPOL | 48.7515 |
| QED | 0.486 |
| Synth | 2.996 |
| Natural Product Likeliness | 0.271 |
| NR-PPAR-gamma | 0.82 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -5.221 |
| MDCK | 0.0000107 |
| BBB | 0.026 |
| PPB | 0.974836 |
| VDSS | 1.195 |
| FU | 0.0134347 |
| CYP1A2-inh | 0.1 |
| CYP1A2-sub | 0.177 |
| CYP2c19-inh | 0.19 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.057 |
| CYP2c9-sub | 0.95 |
| CYP2d6-inh | 0.035 |
| CYP2d6-sub | 0.035 |
| CYP3a4-inh | 0.13 |
| CYP3a4-sub | 0.014 |
| CL | 4.01 |
| T12 | 0.352 |
| hERG | 0.119 |
| Ames | 0.018 |
| ROA | 0.03 |
| SkinSen | 0.955 |
| Carcinogencity | 0.04 |
| EI | 0.931 |
| Respiratory | 0.941 |
| NR-Aromatase | 0.263 |
| Antiviral | Yes |
| Prediction | 0.723382 |